Satter Amends Stake in Aileron Therapeutics

TL;DR

Satter updated their 13D filing for Aileron (ALRN) - check for ownership changes.

AI Summary

Muneer A. Satter, through Satter Investment Management, LLC, has amended their Schedule 13D filing for Aileron Therapeutics, Inc. on April 16, 2024. The filing indicates a change in the beneficial ownership of the company's common stock. Satter Management Co., L.P. is listed as the mailing address for Muneer A. Satter.

Why It Matters

Changes in beneficial ownership filings like this can signal shifts in major investor sentiment or strategy, potentially impacting the stock price of Aileron Therapeutics.

Risk Assessment

Risk Level: medium — Schedule 13D filings indicate significant ownership stakes, and amendments can signal potential strategic moves or changes in investor confidence.

Key Players & Entities

• Muneer A. Satter (person) — Filing party and beneficial owner
• Satter Investment Management, LLC (company) — Entity associated with Muneer A. Satter's filing
• Aileron Therapeutics, Inc. (company) — Subject company
• Satter Management Co., L.P. (company) — Mailing address for Muneer A. Satter

FAQ

Key Financial Figures

• $0.001 — ame of issuer) Common Stock, par value $0.001 (Title of class of securities) 00887A

Filing Documents

• ff3271547_13da6-aileron.htm (SC 13D/A) — 49KB
• 0000895345-24-000124.txt ( ) — 50KB

Interest in Securities of the Issuer

Item 5. Interest in Securities of the Issuer. Items 5(a), (b) of the Prior Filings are hereby deleted and restated as follows: (a), (b) Amount beneficially owned as of the date hereof: Amount beneficially owned: The Reporting Person beneficially owns an aggregate of 830,466 shares of Common Stock. The shares of Common Stock beneficially owned by the Reporting Person include (a) 51,253 shares of Common Stock that are held by Muneer A. Satter Revocable Trust for which the Reporting Person serves as trustee and, in such capacity, has sole voting and dispositive power over all such shares; (b) 61,547 shares of Common Stock that are held by various other trusts and other entities for which the Reporting Person serves as trustee, investment advisor or manager and, in such capacity, has sole voting and dispositive power over all such shares; and (c) 717,666 shares of Common Stock that are held by SMTP for which the Reporting Person has sole voting and dispositive power over all such shares. Percent of class: In the aggregate the Reporting Person beneficially owns 830,466 shares of Common Stock, which amount represents 4.9% of the total number of shares of Common Stock outstanding. All percentages calculated in this Schedule 13D are based on an aggregate of 16,972,512 shares of Common Stock that the Company reported as outstanding as of April 12, 2024 in the Annual Report on Form 10-K filed with the SEC on April 15, 2024.

(e) of the Prior Filings is hereby deleted and restated as follows

Item 5(e) of the Prior Filings is hereby deleted and restated as follows: (e) As of April 2, 2024, upon the expiration of Warrants entitling SMTP to purchase 186,567 shares of Common Stock, the Reporting Person ceased to be the beneficial owner of more than five percent of the shares of Common Stock. Page 3 of 4 Pages

SIGNATURES

SIGNATURES After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: April 16, 2024 /s/ Muneer A. Satter Muneer A. Satter Page 4 of 4 Pages

View Full Filing

View this SC 13D/A filing on SEC EDGAR